INTRODUCTION
Creutzfeldt-Jakob Disease (CJD) is a prominent member of transmissible spongiform encephalopathies, also known as prion diseases, where an abnormal, protease-resistant form (PrP Sc ) of the host encoded prion protein (PrP C ) accumulates in the brain (Prusiner, 1997). PrP Sc is partially resistance to degradative processes, and its accumulation is accompanied by neuronal loss, spongiform change, reactive astrocytosis, and occasionally amyloid plaque deposition (Ironside, 1996) . The distribution of neuropathological features suggests selective neuronal vulnerability (DeArmond et al., 1997; Guentchev et al., 1998) ; moreover, the manifestation of the variability in the disease is supported by recent publication of a molecular classification of sporadic CJD (Parchi et al., 1999) .
The major difference between the normal and disease-associated isoforms of the prion protein (PrP) is a conformational change, leading to the hypothesis that molecular chaperones may be involved in the folding of PrP and hence in the progression of disease (Kenward et al., 1994 (Kenward et al., , 1996 Telling et al, 1995) .
